Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes.

Cell death & disease - 28 Jun 2021

Zhu Yuqian, Song Dandan, Guo Juan, Jin Jiacheng, Tao Ying, Zhang Zheng, Xu Feng, He Qi, Li Xiao, Chang Chunkang, Wu Lingyun

Abstract excerpt

Mutations in the U2 small nuclear RNA auxiliary factor 1 (U2AF1) gene are the common feature of a major subset in myelodysplastic syndromes (MDS). However, the genetic landscape and molecular pathogenesis of oncogenic U2AF1S34F mutation in MDS are not totally understood. We performed comprehensive analysis for prognostic significance of U2AF1 mutations in acute myeloid leukemia (AML) cohort based on The Cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bcl-2-Like Protein 11
Share to Cyclin-Dependent Kinase Inhibitor p27

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Forkhead Box Protein O3

Share to G2 Phase Cell Cycle Checkpoints

Share to Gene Expression Regulation, Leukemic

Share to Inflammasomes

Share to NLR Family, Pyrin Domain-Containing 3 Protein

Share to Splicing Factor U2AF

Source

Open in PubMed Open full text

Identifiers

PMID: 34183647
DOI: 10.1038/s41419-021-03573-3
PMCID: PMC8238956

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes.PMID 34183647Read ↗

The Biological and Clinical Consequences of RNA Splicing Factor U2AF1 Mutation in Myeloid MalignanciesSemantic proximity Read ↗

The Role of U2AF1 Mutation in Malignant Diseases and Related Therapeutic StrategiesSemantic proximity Read ↗

U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review).Semantic proximity Read ↗

Prognostic value of U2AF1 mutant in patients with de novo myelodysplastic syndromes: a meta-analysis.Semantic proximity Read ↗

Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.Semantic proximity Read ↗

Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression.Semantic proximity Read ↗

Prognostic significance of U2AF1 mutations in myelodysplastic syndromes: a meta-analysis.Semantic proximity Read ↗

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromesSemantic proximity Read ↗

U2af1 is required for survival and function of hematopoietic stem/progenitor cells.Semantic proximity Read ↗

Impact of U2AF1 Pathogenic Variants on Prognosis of Myelodysplastic Neoplasms With RUNX1 Mutation.Semantic proximity Read ↗

The splicing factor U2AF1 contributes to cancer progression through a non-canonical role in translation regulationSemantic proximity Read ↗

Splicing factor mutations in the myelodysplastic syndromes: Role of key aberrantly spliced genes in disease pathophysiology and treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.